Immunotherapy is a groundbreaking treatment modality that leverages the immune system to combat various diseases, primarily cancer. As advancements in this field continue to evolve, it is crucial for physicians to comprehend its principles and applications.
Immunotherapy, also known as biological therapy, involves the use of living organisms, substances derived from them, or synthetic versions to enhance or restore immune function. It can be categorized into active, passive, and hybrid forms based on the approach to stimulate the immune response.
Immunotherapy has revolutionized cancer treatment by offering targeted therapies with fewer side effects than traditional treatments. It works either by stimulating the immune system to attack cancer cells or by providing it with components, such as immune system proteins. Checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines are prime examples of this treatment.
Biomarkers play a pivotal role in predicting the response to immunotherapy. Common biomarkers include PD-L1 expression and microsatellite instability. Understanding these biomarkers can guide physicians in choosing the appropriate immunotherapy treatment for individual patients.
While immunotherapy has revolutionized cancer treatment, it is not devoid of side effects. These can range from mild fatigue to severe immune-related adverse events. Early recognition and management of these side effects are crucial to ensure patient safety and treatment efficacy.
Immunotherapy marks a new era in the fight against cancer and other diseases. As the field continues to evolve, physicians must stay abreast of the latest developments to provide the best possible care to their patients. Understanding the fundamentals of immunotherapy, its applications, and potential side effects is key to harnessing its full potential in clinical practice.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation